Teva proposes $40 billion acquisition of competitor MylanAcquisition would create leading company with potential to transform global market for generics.Teva Pharmaceutical Industries building in Jerusalem.(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)
